Free Trial

Omron (OTCMKTS:OMRNY) Sees Unusually-High Trading Volume - What's Next?

Omron logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Unusually-high trading volume: About 433,559 shares traded on Thursday, a 755% increase from the prior session, while the stock dipped to $27.70 from a $29.10 close.
  • Quarterly results missed on EPS: Omron reported $0.17 EPS versus a $0.36 consensus (revenue $1.41B beat $1.38B), with modest profitability (ROE 2.46%, net margin 2.8%) and FY2025 guidance near 0.96 EPS versus sell-side expectations of roughly 0.42 for the current year.
  • Analyst view and ownership: Zacks upgraded Omron from "strong sell" to "hold" and MarketBeat shows a consensus "Hold," while institutional ownership remains very low at about 1.09%.
  • Interested in Omron? Here are five stocks we like better.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report) shares saw unusually-high trading volume on Thursday . Approximately 433,559 shares changed hands during mid-day trading, an increase of 755% from the previous session's volume of 50,706 shares.The stock last traded at $27.70 and had previously closed at $29.10.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Omron from a "strong sell" rating to a "hold" rating in a research note on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of "Hold".

View Our Latest Research Report on OMRNY

Omron Price Performance

The company has a market cap of $5.80 billion, a P/E ratio of 35.58, a P/E/G ratio of 0.45 and a beta of 0.92. The company's 50-day moving average price is $29.50 and its two-hundred day moving average price is $27.57. The company has a current ratio of 2.11, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13.

Omron (OTCMKTS:OMRNY - Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.36 by ($0.19). Omron had a return on equity of 2.46% and a net margin of 2.80%.The firm had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, sell-side analysts expect that Omron Corp. will post 0.42 earnings per share for the current year.

Hedge Funds Weigh In On Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC grew its stake in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 50.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,129 shares of the company's stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $54,000 as of its most recent SEC filing. 1.09% of the stock is owned by institutional investors and hedge funds.

About Omron

(Get Free Report)

Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines